Overweight and obesity: an emerging problem in patients with congenital heart disease

Caroline Andonian1,2,3, Fabian Langer4, Jürgen Beckmann2,5

  • 1Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University Munich, Munich, Germany.

Insights

Adults with congenital heart disease (CHD) face growing rates of obesity due to unhealthy behaviors. This review explores psychosocial factors and calls for integrated nutrition and weight management guidelines for better adult congenital heart disease care.

Area of Science:

  • Cardiology
  • Psychology
  • Public Health

Background:

  • The population of adults with congenital heart disease (ACHD) is increasing due to medical advances.
  • Congenital heart disease (CHD) affects millions of children annually, with ACHD numbers now surpassing pediatric cases.
  • Problematic health behaviors, including physical inactivity and poor nutrition, are prevalent in ACHD patients, contributing to significant overweight and obesity rates.

Purpose of the Study:

  • To examine the psychosocial effects of CHD diagnosis on disordered eating patterns and excess weight.
  • To identify specific risk factors and explanations for the rising obesity prevalence in CHD patients.
  • To highlight the need for evidence-based clinical guidelines for nutrition and weight management in ACHD care.

Main Methods:

  • This article is a review of existing literature.
  • It synthesizes findings on psychosocial impacts and behavioral patterns in ACHD.
  • It analyzes risk factors contributing to obesity in this population.

Main Results:

  • Psychosocial factors associated with CHD diagnosis can influence eating behaviors and weight gain.
  • Specific risk factors contributing to obesity in ACHD patients have been identified.
  • Alarming rates of overweight and obesity are documented in CHD patients, posing risks for further health complications.

Conclusions:

  • There is a critical need for integrated clinical guidelines addressing nutrition and weight management for ACHD patients.
  • A holistic treatment approach is essential for managing the complex health needs of adults with congenital heart disease.
  • Addressing psychosocial aspects alongside physical health is crucial for improving outcomes in ACHD.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
175
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
206
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
633